Yardi to get day in court over software piracy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
BEGA lights the way for local manufacturing resurgence
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Self-driving cars: Disruptions on the road ahead
By Paul Witman Self-driving cars and trucks are making their way from the lab to city streets and highways. Projects from Google, Audi, Tesla and others have made considerable progress in enabling the “driver” just to tell the car where to go and the car does the rest. Uber, the taxi alternative, is testing these Read More →
CalAmp reports $1.5 million loss in net income for third quarter
Oxnard wireless parts maker CalAmp ended the third quarter with a $1.5 million loss in net income, or a 4 cent loss per diluted share, compared to $3.9 million in net income last year, or 11 cents per share. CalAmp was impacted by a legal expense that was $1.6 million more than the comparable period last year Read More →
Soraa LED lamps exceed state certification standards
Goleta-based LED technology company Soraa announced Dec. 22 that its products exceeded the certification needed for California’s Title 24 lighting standard, making it the first company with a complete line of LED lamps to do so. Soraa’s LEDs had both a color rendering index and a deep red rendering index of 95, greater than the Read More →
Amgen seeks to market osteoporosis drug in Japan
Thousand Oaks biotech giant Amgen is seeking marketing approval in Japan for osteoporosis drug romosozumab, the company announced on Dec. 20. Amgen submitted the request to the Pharmaceuticals and Medical Devices Agency in Japan, where an estimated 12 million people have a high risk of bone fracture. The company is co-developing the drug worldwide with Euronext Read More →